调解子单元Med4强化了乳腺癌转移性休眠状态
Seong-Yeon Bae1,2,3,4, Hsiang-Hsi Ling1,2,3,4, Yi Chen2,5,6
1Cancer Metastasis Initiative, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York 10032, USA.
bioRxiv : the preprint server for biology
|November 28, 2023
概括
Med4蛋白作为休眠乳腺癌细胞的守门员,防止它们的重新激活和转移生长. 它的缺乏与较差的患者预后有关,强调Med4作为高风险复发的潜在生物标志物.
科学领域:
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 乳腺癌患者的长期生存往往受到转移性休眠癌细胞复发的影响.
- 控制这些休眠细胞的生存和重新激活的精确机制尚不清楚.
研究的目的:
- 鉴定乳腺癌转移性再激活的新型调节剂.
- 阐明Med4在维持癌细胞休眠和转移潜力的作用.
主要方法:
- 在小鼠中进行基因组规模的基因查,以确定涉及转移性活性化的基因.
- 同基因异种移植模型研究Med4在乳腺癌休眠期的功能.
- 染色体免疫沉和基因表达分析,以调查Med4的调节机制.
主要成果:
- Med4被确定为一个关键的守门员,抑制转移性活化.
- 在转移性乳腺癌患者中普遍存在的Med4哈普隆缺陷与更差的预后相关.
- Med4通过抑制H3K4me1沉积来维持3D染色质紧缩,并抑制增强剂原始化,从而强制休眠.
- 缺少Med4会破坏增强剂的动态,促进细胞外基因表达,促进转移性生长.
结论:
- Med4是乳腺癌中细胞休眠的关键调节剂.
- 在中介体内,Med4具有独特的功能,维护染色质结构并防止转移性活化.
- 在乳腺癌患者中,Med4作为预测高风险转移性复发的潜在生物标志物.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


